This article is publication 20 from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study, which is registered with ClinicalTrials.gov (NCT00096733).
Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy
Article first published online: 11 MAR 2013
Copyright © 2013 American Association for the Study of Liver Diseases
Volume 19, Issue 3, pages 292–304, March 2013
How to Cite
Everson, G. T., Hoefs, J. C., Niemann, C. U., Olthoff, K. M., Dupuis, R., Lauriski, S., Herman, A., Milne, N., Gillespie, B. W., Goodrich, N. P. and Everhart, J. E. (2013), Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy. Liver Transpl, 19: 292–304. doi: 10.1002/lt.23592
In addition to the institutions affiliated with the authors, the Adult-to-Adult Living Donor Liver Transplantation Cohort Study includes Northwestern University (Chicago, IL), the University of California Los Angeles (Los Angeles, CA), Columbia University Health Sciences, NY, NY, University of Virginia, Charlottesville, VA, and Virginia Commonwealth University (Richmond, VA).
Gregory T. Everson and Claus U. Niemann were the principal investigators at the 2 clinical centers at the University of Colorado and the University of California San Francisco, respectively. John C. Hoefs and Norah Milne were responsible for the analyses of single-photon emission computed tomography liver-spleen scans. Kim M. Olthoff participated in the preparation of the manuscript. Robert Dupuis analyzed the erythromycin breath tests, and Shannon Lauriski analyzed the cholate clearances and shunt and the caffeine and galactose samples. Andrea Herman was the study coordinator in Colorado. Brenda W. Gillespie and Nathan P. Goodrich performed the statistical analyses. James E. Everhart was the project officer from National Institute of Diabetes and Digestive and Kidney Diseases.
Gregory T. Everson has intellectual property rights related to the filing (by the University of Colorado Denver) of US patent application 60/647,689 (Methods for Diagnosis and Intervention of Hepatic Disorders) on January 26, 2005 and International Application PCT/US2006/003132 as published under the Patent Cooperation Treaty, World Intellectual Property Organization, International Patent Classification A61K 49/00 (2006.01), International Publication Number WO 2006/081521 A2 on August 3, 2006. Everson also has an equity interest in HepQuant LLC. The other authors have no financial relationships to disclose.
This study was supported by the National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases (grants U01-DK62536, U01-DK62444, U01-DK62467, U01-DK62483, U01-DK62484, U01-DK62494, U01-DK62496, U01-DK62498, U01-DK62505, and U01-DK62531) and by the University of California Irvine (contract 38643).
- Issue published online: 11 MAR 2013
- Article first published online: 11 MAR 2013
- Accepted manuscript online: 13 DEC 2012 04:58AM EST
- Manuscript Accepted: 6 NOV 2012
- Manuscript Received: 26 OCT 2012
- 3for Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Laboratory test results after living liver donation in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Liver Transpl 2011;17:409–417., , , , , , et al.;
- 14for HALT-C Trial Group. Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt. Aliment Pharmacol Ther 2007;26:401–410., , , , , ;
- 15for HALT-C Trial Group. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-Viral Long-Term Treatment Against Cirrhosis Trial. Aliment Pharmacol Ther 2008;27:798–809., , , , , , et al.;
- 17for HALT-C Trial Group. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial. Hepatology 2012;55:1019–1029., , , , , , et al.;
- 26Cytochrome P450 activity and the acute phase response in healthy donors after living donor liver transplantation (LDLT) [abstract]. Hepatology 2004;40(suppl S4):561A., , , , , .
- 27Spleen volume and platelet count changes among donors after living donor liver transplantation. Hepatogastroenterology 2008;55:1211–1215., , , , , , et al.